IPMK and Huntington disease: Studies by Ahmed et al. [90] demonstrated a significant loss of IPMK in the striatal brain samples of both humans and mice with Huntington’s disease (HD), suggesting IPMK’s involvement in the pathogenesis of this neurodegenerative disorder.